Untargeted Metabolic Profiling of Cat Urine and Plasma in Hypertension.

Metabolic profiling of urine and plasma can aid in non-invasive detection of feline hypertension.

Hypertension in cats is a significant concern, yet early detection remains challenging due to the lack of routine blood pressure screening and potential white coat syndrome. This study aimed to identify metabolic alterations in the urine and plasma of hypertensive cats to enhance understanding of the disease's pathogenesis and discover potential biomarkers. The researchers employed untargeted metabolic profiling techniques to analyze urine and plasma samples from hypertensive and normotensive cats. The findings revealed distinct metabolic signatures associated with hypertension, including changes in amino acid metabolism, lipid metabolism, and energy production pathways. These alterations suggest that hypertension in cats may disrupt normal metabolic processes, leading to the accumulation of specific metabolites. The study also identified potential biomarkers that could aid in the non-invasive diagnosis of hypertension, offering a promising alternative to traditional blood pressure measurements. By understanding the metabolic changes associated with hypertension, veterinarians can improve early detection and management of the condition, potentially reducing the risk of associated complications such as kidney disease and retinal damage. The research underscores the importance of integrating metabolic profiling into veterinary practice to enhance diagnostic capabilities and patient outcomes.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.